| HOME >> BIOLOGY >> TECHNOLOGY |
Edward H. Myles, Senior Vice President of Finance & CFO
PressureBioSciences, Inc.
(T) 508-580-1818
Consolidated Statements of Operations
(UNAUDITED)
For the Three For the Six
Months Ended Months Ended
June 30, June 30,
2007 2006 2007 2006
REVENUE:
PCT Products, services, other $136,355 $28,783 $174,297 $82,197
Grant revenue 65,772 - 159,451 -
Total revenue 202,127 28,783 333,748 82,197
COSTS AND EXPENSES:
Cost of PCT products and
services 57,629 47,104 89,282 98,650
Research and development 538,015 401,500 999,547 660,319
Selling and marketing 350,823 128,005 607,354 195,384
General and administrative 624,462 595,481 1,105,544 1,285,107
Total operating costs and
expenses 1,570,929 1,172,090 2,801,727 2,239,460
Operating loss from
continuing operations (1,368,802)(1,143,307)(2,467,979) (2,157,263)
OTHER INCOME:
Realized gain on securities
available for sale 1,301,247 - 2,028,720 517,938
Interest income 80,482 109,287 152,084 217,792
Total other income 1,381,729 109,287 2,180,804 735,730
Income (loss) from
continuing operations
before income taxes 12,927 (1,034,020) (287,175) (1,421,533)
Income tax benefit from
continuing operations 3,516 219,759 44,035
'/>"/>
SOURCE Pressure BioSciences, Inc.![]() Copyright©2007 PR Newswire. |